Latest Breaking News On - James coulston - Page 1 : vimarsana.com

Stock awards continue as bulk of ProKidney exec compensation

Stock awards continue as bulk of ProKidney exec compensation
journalnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalnow.com Daily Mail and Mail on Sunday newspapers.

James coulstonTim bertramTodd girolamoDeepak jainBruce culletonBusiness centerProkidney corpGreenbourne drive

Major ProKidney investor sells off bulk of company shares

Major ProKidney investor sells off bulk of company shares
journalnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalnow.com Daily Mail and Mail on Sunday newspapers.

Pablo legorretaJames coulstonChamath palihapitiyaBruce culletonTim bertramAaron cowenDrug administrationCapital suvretta holdings corpClinical developmentProkidney corpSocial capital suvretta holdingsMonday prokidneyControl empresarial de capitalesRenal autologous cell therapy

ProKidney Corp (NASDAQ:PROK) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the ProKidney Corporate Update Conference Call. At this time, all lines are in a listen-only mode.

United statesPablo legorretaDarin weberGlenn schulmanBruce culletonYigal nochomovitzAlan lotvinTim bertramBrian pereiraJames coulstonProkidney corpUniversity of calgaryNational kidney foundationProkidney coCall transcript novemberProkidney corporate update conference

ProKidney Reports Third Quarter Financial Results

WINSTON-SALEM, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics.

Glenn schulmanJames coulstonExchange of classExchange commissionCapital suvretta holdings corpCompany classLifesci advisorsProkidney corpChief financial officerLoss before noncontrolling interestRenal autologous cell therapyRegenerative medicine advanced therapyPrivate securities litigation reform actAnnual reportQuarterly reportsSci advisors

Winston-Salem loss could be Greensboro gain with ProKidney

ProKidney Corp., one of Winston-Salem’s newest publicly traded companies, is preparing to take a major step with its medical research and commercialization plans.

North carolinaUnited statesGuilford countyWinston salemForsyth countyPablo legorretaWilliam doyleJames coulstonBrian pereiraDeepak jainTim bertramMarc wuchererJohn maraganoreAlan lotvinCarolina fundGreensboro city council